Brucella anthropi bacteremia: Persistent bacteremia with minimal symptoms

IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES Journal of Infection and Chemotherapy Pub Date : 2025-03-01 Epub Date: 2024-12-20 DOI:10.1016/j.jiac.2024.102595
Sho Yokota , Toshibumi Taniguchi , Shin Takayanagi
{"title":"Brucella anthropi bacteremia: Persistent bacteremia with minimal symptoms","authors":"Sho Yokota ,&nbsp;Toshibumi Taniguchi ,&nbsp;Shin Takayanagi","doi":"10.1016/j.jiac.2024.102595","DOIUrl":null,"url":null,"abstract":"<div><div><em>Brucella anthropi</em>, an aerobic, glucose-nonfermenting gram-negative rod, is predominantly an opportunistic pathogen affecting immunosuppressed patients. This case report describes a 27-year-old woman with systemic lupus erythematosus who developed persistent <em>B. anthropi</em> bacteremia following a pregnancy termination. Despite her stable condition and minimal symptoms, including transient fever, blood cultures revealed persistent bacteremia. Initial treatment with ceftazidime was ineffective due to resistance, leading to a switch to ciprofloxacin, which ultimately resolved the bacteremia. This case underscores the challenges in identifying the source of infection in the absence of typical symptoms and highlights the importance of vigilance in monitoring for persistent bacteremia, even in clinically stable patients. Our findings suggest that symptom improvement does not guarantee the resolution of bacteremia, propose follow-up blood cultures to ensure effective management of <em>B. anthropi</em> bacteremia.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"31 3","pages":"Article 102595"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X24003428","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Brucella anthropi, an aerobic, glucose-nonfermenting gram-negative rod, is predominantly an opportunistic pathogen affecting immunosuppressed patients. This case report describes a 27-year-old woman with systemic lupus erythematosus who developed persistent B. anthropi bacteremia following a pregnancy termination. Despite her stable condition and minimal symptoms, including transient fever, blood cultures revealed persistent bacteremia. Initial treatment with ceftazidime was ineffective due to resistance, leading to a switch to ciprofloxacin, which ultimately resolved the bacteremia. This case underscores the challenges in identifying the source of infection in the absence of typical symptoms and highlights the importance of vigilance in monitoring for persistent bacteremia, even in clinically stable patients. Our findings suggest that symptom improvement does not guarantee the resolution of bacteremia, propose follow-up blood cultures to ensure effective management of B. anthropi bacteremia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人布鲁氏菌菌血症:伴有轻微症状的持续性菌血症。
人类布鲁氏菌是一种需氧、葡萄糖不发酵的革兰氏阴性棒,主要是影响免疫抑制患者的机会性病原体。本病例报告描述了一位27岁的系统性红斑狼疮妇女,她在妊娠终止后出现了持续的人芽胞杆菌菌血症。尽管她病情稳定,症状轻微,包括短暂发热,但血液培养显示持续菌血症。由于耐药,最初使用头孢他啶治疗无效,导致改用环丙沙星,最终解决了菌血症。该病例强调了在没有典型症状的情况下确定感染源的挑战,并强调了监测持续性菌血症的重要性,即使在临床稳定的患者中也是如此。我们的研究结果表明,症状的改善并不能保证菌血症的解决,建议随访血培养以确保有效管理人芽胞杆菌菌血症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy INFECTIOUS DISEASES-PHARMACOLOGY & PHARMACY
CiteScore
4.10
自引率
4.50%
发文量
303
审稿时长
47 days
期刊介绍: The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.
期刊最新文献
Comparison of baloxavir/marboxil treatment and treatment with other anti-influenza agents in adult patients hospitalized for influenza: An internet-based, prospective, multicenter, cohort study in Japan Severe polyneuropathy in HIV-negative human herpesvirus 8–associated multicentric Castleman disease successfully treated with rituximab and liposomal doxorubicin Barriers to pediatric COVID-19 vaccination in Japan: A parent survey on convenience and access Pharmacokinetic interaction between nirmatrelvir/ritonavir and nifedipine: A case report Infectious mononucleosis mimicking Fitz-Hugh–Curtis Syndrome: The diagnostic complexity of concurrent Chlamydia trachomatis infection and false-positive syphilis serology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1